Glaxosmithkline | GSK - Ebitda





Ebitda Changement Date
AbbVie USD 6.91B 3.22B 2026-06
Amgen USD 5.8B 1.25B 2026-09
AstraZeneca USD 7.46B 2.3B 2026-09
Aurora Cannabis CAD 799K 2.9M 2026-06
Bausch Health Companies USD 1.31B 230M 2026-09
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Canopy Growth CAD 8M 145M 2026-06
Corcept Therapeutics USD 115.75M 73.59M 2026-09
Drreddys Laboratories INR 18.79B 10.16B 2026-09
Eli Lilly USD 9.46B 3.54B 2026-09
GlaxoSmithKline GBP 3.51B 734M 2026-06
Glaxosmithkline GBP 2.93B 154M 2026-09
J&J USD 8.99B 721M 2026-06
Merck USD 1.42B 2.97B 2026-06
Novartis USD 8.62B 2.14B 2026-09
Pacira USD 50.45M 1.78M 2026-09
Perrigo USD 156.6M 83M 2026-09
Pfizer USD 6.36B 350M 2026-09
Phibro Animal Health USD 68.1M 6.2M 2025-12
Prestige Brands USD 89.44M 28.2M 2026-09
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 5.79B 2.1B 2026-09
Supernus Pharmaceuticals USD 55.6M 24M 2026-09
Takeda JPY 369.75B 5.29B 2026-09
Teva Pharmaceutical Industries USD 1.5B 1.02B 2026-09
Zoetis USD 1.07B 21M 2026-09